Environmental polysaccharide analysis: composition and purity identification

Dans l’industrie biopharmaceutique, l’etude des polysaccharides environnementaux repond a des enjeux critiques de composition, de purete, d’homogeneite et de maitrise des impuretes. Ces matrices peuvent presenter une forte variabilite structurale : distribution de masses molaires, heterogeneite des chaines, presence de residus saccharidiques differents, contaminants organiques traces ou composes residuels issus du procede. Une analyse polysaccharides fiable permet de confirmer l’identite de l’echantillon, de comparer des lots, d’investiguer une non-conformite et d’appuyer les travaux de developpement, de qualification fournisseur ou de retro-ingenierie.

Composition identification is based on tests capable of describing the nature of the saccharide polymer and its constituents. Depending on the need, the analysis focuses on monosaccharide composition, comparison of fragments after extraction, highlighting chain-length differences, and molecular weight characterization by SEC/GPC. For certain products such as hyaluronic acid, it is possible to implement a quantification method adapted to the matrix. Additional investigations by LC-HRMS can also be carried out to identify a specific impurity or support a de-formulation approach.

Impurity screening may target residual compounds, organic additives, solvents, oligomers, trace reagents, or contaminants originating from formulation and packaging. Depending on their volatility and polarity, they can be screened by HS-GC/MS, GC/MS, or LC-HRMS after extraction. This approach is particularly useful for identifying plasticizers, antioxidants, UV stabilizers, semi-volatile compounds, or non-volatile compounds. In some cases, pyrolysis-GC/MS provides complementary insight into the nature of the material and certain additives. For related investigations on biomolecules, also see our page Biopharmaceutical Peptide Identification.

The technical means available include SEC/GPC for molecular weight and aggregates, LC-HRMS/MS for impurity and modification identification, GC/MS and HS-GC/MS for volatile and semi-volatile compounds, pyrolysis-GC/MS for characterizing certain organic constituents, as well as measurements of viscosity, viscoelastic properties, thermal stability by DSC, solubility, and chromatographic profile. When the matrix requires it, elemental or morphological characterization approaches can complement the study to document mineral loads or particulate contaminants. For adjacent needs in surface characterization and cleanliness, also see Xps Layer Purity.

Our laboratory supports manufacturers with a results-driven biopharmaceutical analysis approach. We combine separation, spectrometric, and physicochemical methods to establish the composition profile, assess purity, and detect relevant impurities. This expertise notably covers carbohydrate structure elucidation, monosaccharide composition, product homogeneity assessment, fragment screening, aggregate quantification, charge variant studies, and the identification of trace organic compounds. Depending on the objective, the investigation can be complemented by a Chemical Substance Identification Laboratory.

Purity is not limited to the absence of visible contaminants. It also involves assessing product homogeneity, quantifying aggregates by size-exclusion chromatography, studying chromatographic profiles, and screening for variants or fragments. Physicochemical properties such as solubility, solution stability, viscosity, viscoelastic properties, or thermal stability can be measured to assess the overall compliance of the sample and its behavior in industrial use.

Beyond detection, the challenge is to use the data to act quickly: supplier qualification, formulation comparison, compliance verification, understanding a process drift, or supporting a contradictory expert assessment. Cross-analysis of the results makes it possible to distinguish a structural signal, a synthesis impurity, a crosslinking residue, an exogenous contamination, or a composition variation. This integrated reading is essential to ensure reliable decisions in R&D, quality, and production.

Choosing Filab means benefiting from a partner capable of building a tailor-made analytical strategy based on your industrial need: confirming a composition, comparing batches, identifying an impurity, supporting de-formulation, or documenting a technical file. Our approach prioritizes the relevance of the tests, the robustness of the interpretations, and rapid implementation, with deliverables that can be used by quality, R&D, regulatory affairs, and production teams.

Filab supports biopharmaceutical manufacturers to analyze the composition of a polysaccharide, identify an impurity, compare a compliant batch and a non-compliant batch, measure a molecular weight or viscosity, and secure a formulation before industrial-scale production. This ability to combine chemical characterization, impurity investigation, and industry-specific interpretation is a concrete lever for controlling your products and processes. For related topics in the characterization of complex materials, you can also consult Nanomaterials Industrial Coatings.